Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Accounts Payable: HK$148 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Shenzhen Neptunus Interlong Bio-Technique Co Accounts Payable?

Shenzhen Neptunus Interlong Bio-Technique Co HKSE:08329 +4.04% Accounts Payable is HK$148 Mil as of Jun. 2026. The stock has 3 warning signs investors should review.

Shenzhen Neptunus Interlong Bio-Technique Co's Accounts Payable for the quarter that ended in Jun. 2026 was HK$148 Mil.

Shenzhen Neptunus Interlong Bio-Technique Co's quarterly Accounts Payable increased from Jun. 2025 (HK$133 Mil) to Dec. 2025 (HK$159 Mil) but then declined from Dec. 2025 (HK$159 Mil) to Jun. 2026 (HK$148 Mil).

Shenzhen Neptunus Interlong Bio-Technique Co's annual Accounts Payable declined from Dec. 2023 (HK$164 Mil) to Dec. 2024 (HK$153 Mil) but then increased from Dec. 2024 (HK$153 Mil) to Dec. 2025 (HK$159 Mil).

Shenzhen Neptunus Interlong Bio-Technique Co Accounts Payable Related Terms

Shenzhen Neptunus Interlong Bio-Technique Co Accounts Payable Historical Data

* Premium members only.

The historical data trend for Shenzhen Neptunus Interlong Bio-Technique Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen Neptunus Interlong Bio-Technique Co Accounts Payable Chart

Shenzhen Neptunus Interlong Bio-Technique Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 117.77 128.00 164.30 152.51 158.51

Shenzhen Neptunus Interlong Bio-Technique Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 144.16 152.51 133.18 158.51 148.25

Shenzhen Neptunus Interlong Bio-Technique Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of HK$148 Mil mean?
Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) has a Accounts Payable of HK$148 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Shenzhen Neptunus Interlong Bio-Technique Co and its competitors.
Is Shenzhen Neptunus Interlong Bio-Technique Co's Accounts Payable too high?
Shenzhen Neptunus Interlong Bio-Technique Co's current Accounts Payable is HK$148 Mil.
How does Shenzhen Neptunus Interlong Bio-Technique Co's Accounts Payable compare to ZTS?
Shenzhen Neptunus Interlong Bio-Technique Co's Accounts Payable of HK$148 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Shenzhen Neptunus Interlong Bio-Technique Co and its competitors. Shenzhen Neptunus Interlong Bio-Technique Co's current Accounts Payable is HK$148 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Neptunus Interlong Bio-Technique Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.13, compared to a current price of HK$0.10 — trading 20.8% below its estimated fair value. The current Accounts Payable is HK$148 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329), the current Accounts Payable is HK$148 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shenzhen Neptunus Interlong Bio-Technique Co Business Description

Address 979 King’s Road, 43rd Floor, One Taikoo Place, Quarry Bay, Hong Kong, HKG
Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sale of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines and medical devices; and the Sales and distribution of medicines, healthcare products, and medical devices.. The majority of revenue is generated from the Manufacturing and selling of medicines and medical devices segment.